dermatarx.com (DRMA) - נפח מכירות החברה

Dermata Therapeutics (DRMA) is implementing robotic systems for the precise mixing of dermatological formulations. This automation complements management's focus on freshwater sponge innovations, which supports the company's gross sales volume, where 0.00 reflects the metric's baseline. The business is currently conducting early-stage tests independently, limiting partnerships solely to local distribution licensing.

This indicator captures the total cash inflows from product sales, allowing for an assessment of the business's ability to service current liabilities and avoid liquidity gaps. Since Dermata Therapeutics (DRMA) is in the clinical trial stage, the company's commercial revenue remains zero on the chart, confirming that the issuer's financial stability is entirely dependent on external investments and future R&D success.